Author

Marianela Candolfi

Consejo Nacional de Investigaciones Científicas y TécnicasORCID 0000-0002-0843-6568Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Nazareno GonzáleziD· 2 shared Abril MarchesiniiD· 1 shared Alejandro J. Nicola CandiaiD· 1 shared Ana Clara Romero· 1 shared Guillermo Videla Richardson· 1 shared Jorge Armando Pena AgudeloiD· 1 shared Leslie C. Amorós MoralesiD· 1 shared Ma. Luján Scalise· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Nazareno GonzálezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification and validation of drugs for repurposing in Glioblastoma: a computational and experimental workflow

Nazareno González, Melanie Pérez Küper, Matías Garcia Fallit, Jorge Armando Pena Agudelo, Alejandro J. Nicola Candia, Maicol Suarez Velandia, Ana Clara Romero, Guillermo Videla Richardson, Marianela Candolfi

This paper develops a computational and experimental workflow to identify and validate repurposed drugs for Glioblastoma treatment, finding that Etoposide and Cisplatin are more effective than Temozolomide.

Brain Sciences · Jun 13, 2025Peer-reviewedCancer Biology

Role of RIPK1 in Diffuse Gliomas pathology

Leslie C. Amorós Morales, Santiago M. Gómez Bergna, Abril Marchesini, Ma. Luján Scalise, Nazareno González, Marianela Candolfi, Vı́ctor Romanowski, Matías L. Pidre

The paper investigates RIPK1 expression in Diffuse Gliomas using TCGA data, finding higher RIPK1 expression in wild-type IDH tumors and associating it with poor prognosis and immune infiltration.

bioRxiv · Nov 11, 2023 · PreprintBioinformatics